Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

UCB Pharma AB (Sweden)

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 233,450 Less Arrow 211,447 Less Arrow 199,742
Financial expenses 705 Less Arrow 492 Less Arrow 147
Earnings before taxes 12,192 Less Arrow 10,169 Less Arrow 9,831
EBITDA 12,185 Less Arrow 10,492 Less Arrow 9,929
Total assets 168,065 Less Arrow 132,139 Less Arrow 115,250
Current assets 168,065 Less Arrow 132,139 Less Arrow 115,250
Current liabilities 104,625 Less Arrow 70,564 Less Arrow 53,728
Equity capital 63,440 Less Arrow 61,575 Less Arrow 61,522
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 35 Less Arrow 30 More Arrow 31

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.7% More Arrow 46.6% More Arrow 53.4%
Turnover per employee 6,670 More Arrow 7,048 Less Arrow 6,443
Profit as a percentage of turnover 5.2% Less Arrow 4.8% More Arrow 4.9%
Return on assets (ROA) 7.7% More Arrow 8.1% More Arrow 8.7%
Current ratio 160.6% More Arrow 187.3% More Arrow 214.5%
Return on equity (ROE) 19.2% Less Arrow 16.5% Less Arrow 16.0%
Change turnover 22,003 Less Arrow 11,705 Less Arrow 9,849
Change turnover % 10% Less Arrow 6% Less Arrow 5%
Chg. No. of employees 5 Less Arrow -1 More Arrow 5
Chg. No. of employees % 17% Less Arrow -3% More Arrow 19%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.